share_log

新诺威:关于控股子公司SYS6005抗体药物偶联物获得药物临床试验批准通知书的公告

New Novus: Announcement on the holding subsidiary SYS6005 antibody drug conjugate obtaining approval notice for drug clinical trials

SZSI ·  Dec 20, 2024 15:54

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.